Poland· PL-100375292
Qtern
A saxagliptin and dapagliflozin product containing saxagliptinum + dapagliflozinum, registered in Poland by AstraZeneca AB. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Saxagliptin and dapagliflozin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD21 (saxagliptin and dapagliflozin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Saxagliptin and dapagliflozin · ATC A10BD21
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Saxagliptinum + Dapagliflozinum
- Manufacturer
- AstraZeneca AB
- Country
- Poland (PL)
- ATC code
- A10BD21
- ATC class
- Saxagliptin and dapagliflozin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05000456010986
- gtin05000456010979
- gtin05000456061049
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Saxagliptin and dapagliflozin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDAPAGLIFLOZIN AND SAXAGLIPTINNovadoz Pharmaceuticals LLC
- SwitzerlandQtern, FilmtablettenAstraZeneca AG
- SpainQTERN 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAstrazeneca Ab
- United KingdomQtern 5mg/10mg tabletsAstraZeneca UK Ltd
- IrelandQtern 5 mg/10 mg film-coated tabletsAstraZeneca AB
- IcelandQternAstraZeneca AB*
- NetherlandsQtern, filmomhulde tablettenAstraZeneca AB
- SwedenQtern 5 mg/10 mg Filmdragerad tablettAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Qtern
- Liechtenstein · Qtern
- Norway · Qtern
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/02a5c56c-8963-4d9a-83e9-e67bb38c8147 GET /v1/drugs/02a5c56c-8963-4d9a-83e9-e67bb38c8147?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg + 10 mg",
"packaging": "05000456010986 ¦ Rp ¦ Skasowane ¦ EU/1/16/1108/001 ¦ 117091\n14 tabl.\nRp ¦ EU/1/16/1108/002 ¦ 117092\n28 tabl.\n05000456010979 ¦ Rp ¦ Eu/1/16/1108/003 ¦ 117093\n98 tabl.\nRp ¦ EU/1/16/1108/004 ¦ 117094\n30 tabl.\n05000456061049 ¦ Rp ¦ EU/1/16/1108/001 ¦ 135578\n14 tabl.",
"substance": "Saxagliptinum 5 mg + Dapagliflozinum 10 mg",
"common_name": "Saxagliptinum + Dapagliflozinum",
"pl_product_id": "100375292",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about saxagliptin and dapagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.